Anbio Biotechnology

Anbio Biotechnology is a global in vitro diagnostics (IVD) company that specializes in the research, development, and manufacturing of rapid diagnostic solutions. The company provides a diverse range of products, including point-of-care testing (POCT) systems, chemiluminescence immunoassays (CLIA), and molecular diagnostic kits. Their extensive test menu addresses critical clinical needs in cardiovascular health, infectious diseases, oncology, and metabolic disorders. Anbio's products are utilized in hospitals, clinics, and laboratories across more than 100 countries. By leveraging advanced technologies like fluorescence and colloidal gold, the company aims to make high-quality diagnostics more accessible and affordable worldwide.